日本新薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/09/18 | 3,349 | 3,379 | 3,331 | 3,351 | +11 | +0.3% | 213,100 |
| 2024/09/17 | 3,378 | 3,390 | 3,316 | 3,340 | -4 | -0.1% | 218,300 |
| 2024/09/13 | 3,380 | 3,393 | 3,336 | 3,344 | -55 | -1.6% | 241,600 |
| 2024/09/12 | 3,411 | 3,443 | 3,376 | 3,399 | +14 | +0.4% | 260,000 |
| 2024/09/11 | 3,454 | 3,460 | 3,367 | 3,385 | -51 | -1.5% | 258,100 |
| 2024/09/10 | 3,431 | 3,482 | 3,430 | 3,436 | -30 | -0.9% | 301,900 |
| 2024/09/09 | 3,450 | 3,493 | 3,428 | 3,466 | -39 | -1.1% | 231,300 |
| 2024/09/06 | 3,577 | 3,579 | 3,491 | 3,505 | -21 | -0.6% | 219,800 |
| 2024/09/05 | 3,494 | 3,539 | 3,470 | 3,526 | +38 | +1.1% | 272,000 |
| 2024/09/04 | 3,510 | 3,578 | 3,474 | 3,488 | -92 | -2.6% | 419,900 |
| 2024/09/03 | 3,493 | 3,593 | 3,489 | 3,580 | +119 | +3.4% | 259,100 |
| 2024/09/02 | 3,526 | 3,526 | 3,430 | 3,461 | -51 | -1.5% | 277,500 |
| 2024/08/30 | 3,522 | 3,527 | 3,490 | 3,512 | -2 | -0.1% | 362,200 |
| 2024/08/29 | 3,563 | 3,563 | 3,481 | 3,514 | -58 | -1.6% | 353,500 |
| 2024/08/28 | 3,601 | 3,609 | 3,525 | 3,572 | -58 | -1.6% | 379,000 |
| 2024/08/27 | 3,521 | 3,630 | 3,521 | 3,630 | +137 | +3.9% | 324,000 |
| 2024/08/26 | 3,510 | 3,519 | 3,476 | 3,493 | -34 | -1% | 234,400 |
| 2024/08/23 | 3,548 | 3,570 | 3,527 | 3,527 | -23 | -0.6% | 229,400 |
| 2024/08/22 | 3,458 | 3,559 | 3,458 | 3,550 | +113 | +3.3% | 310,400 |
| 2024/08/21 | 3,449 | 3,510 | 3,420 | 3,437 | -57 | -1.6% | 391,000 |
| 2024/08/20 | 3,428 | 3,510 | 3,414 | 3,494 | +127 | +3.8% | 314,100 |
| 2024/08/19 | 3,394 | 3,424 | 3,345 | 3,367 | -17 | -0.5% | 365,000 |
| 2024/08/16 | 3,375 | 3,416 | 3,338 | 3,384 | +57 | +1.7% | 431,800 |
| 2024/08/15 | 3,321 | 3,341 | 3,303 | 3,327 | -14 | -0.4% | 272,200 |
| 2024/08/14 | 3,392 | 3,420 | 3,324 | 3,341 | -52 | -1.5% | 315,400 |
| 2024/08/13 | 3,254 | 3,397 | 3,250 | 3,393 | +156 | +4.8% | 597,500 |
| 2024/08/09 | 3,259 | 3,375 | 3,204 | 3,237 | -39 | -1.2% | 773,200 |
| 2024/08/08 | 3,378 | 3,378 | 3,213 | 3,276 | +248 | +8.2% | 912,400 |
| 2024/08/07 | 3,005 | 3,148 | 2,964 | 3,028 | -47 | -1.5% | 542,900 |
| 2024/08/06 | 3,012 | 3,193 | 3,011 | 3,075 | +174.5 | +6% | 534,100 |
| 2024/08/05 | 3,047 | 3,129 | 2,875 | 2,900.5 | -327.5 | -10.1% | 710,400 |
| 2024/08/02 | 3,287 | 3,295 | 3,222 | 3,228 | -146 | -4.3% | 371,600 |
| 2024/08/01 | 3,400 | 3,423 | 3,355 | 3,374 | -75 | -2.2% | 214,600 |
| 2024/07/31 | 3,460 | 3,482 | 3,424 | 3,449 | ±0 | ±0% | 457,000 |
| 2024/07/30 | 3,452 | 3,470 | 3,414 | 3,449 | -3 | -0.1% | 295,900 |
| 2024/07/29 | 3,442 | 3,481 | 3,442 | 3,452 | +29 | +0.8% | 221,700 |
| 2024/07/26 | 3,458 | 3,503 | 3,421 | 3,423 | +8 | +0.2% | 277,900 |
| 2024/07/25 | 3,440 | 3,455 | 3,406 | 3,415 | +9 | +0.3% | 373,100 |
| 2024/07/24 | 3,428 | 3,447 | 3,363 | 3,406 | -47 | -1.4% | 322,800 |
| 2024/07/23 | 3,440 | 3,466 | 3,427 | 3,453 | +8 | +0.2% | 247,400 |
| 2024/07/22 | 3,469 | 3,472 | 3,432 | 3,445 | -15 | -0.4% | 182,800 |
| 2024/07/19 | 3,470 | 3,470 | 3,421 | 3,460 | -4 | -0.1% | 224,500 |
| 2024/07/18 | 3,435 | 3,472 | 3,413 | 3,464 | +11 | +0.3% | 425,800 |
| 2024/07/17 | 3,517 | 3,517 | 3,440 | 3,453 | -36 | -1% | 312,300 |
| 2024/07/16 | 3,575 | 3,578 | 3,478 | 3,489 | -75 | -2.1% | 386,400 |
| 2024/07/12 | 3,536 | 3,582 | 3,536 | 3,564 | +20 | +0.6% | 308,300 |
| 2024/07/11 | 3,490 | 3,554 | 3,470 | 3,544 | +92 | +2.7% | 460,100 |
| 2024/07/10 | 3,434 | 3,456 | 3,415 | 3,452 | +12 | +0.3% | 237,100 |
| 2024/07/09 | 3,410 | 3,448 | 3,383 | 3,440 | +32 | +0.9% | 333,600 |
| 2024/07/08 | 3,399 | 3,419 | 3,380 | 3,408 | +20 | +0.6% | 257,900 |
151～
200
件表示中 / 3692件
類似銘柄と比較する
現在ご覧いただいている「日本新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 日本新薬 | 373,500円 | +7.9% | +8.9% | 3.32% | 7.99倍 | 1.07倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
| ツムラ | 430,100円 | +20.9% | +87.3% | 3.16% | 9.61倍 | 1.11倍 |
|
医療用漢方薬で国内シェア８割超。高齢者、がん支持療法、女性関連の３領域を重点に市場深耕 |
| ペプチド | 201,800円 | +5.0% | +1.5% | 0.00% | 17.33倍 | 4.61倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
| サワイＧＨＤ | 203,300円 | +4.0% | +25.4% | 2.61% | 8.89倍 | 1.17倍 |
|
ジェネリック（後発）薬大手メーカー。２１年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
| 科研薬 | 407,200円 | +30.5% | +111.0% | 4.67% | 11.48倍 | 1.00倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
市場注目の銘柄
チャート関連のコラム
